| Title |
Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, December 2011
|
| DOI | 10.1007/s00228-011-1188-z |
| Pubmed ID | |
| Authors |
Jolyce Bourgeois, Monique M. Elseviers, Majda Azermai, Luc Van Bortel, Mirko Petrovic, Robert R. Vander Stichele |
| Abstract |
(1) To describe the prevalence of benzodiazepine use in Belgian nursing homes, with specific attention to indications and dosages. (2) To compare actual and recommended dosages of benzodiazepines for anxiety and insomnia. (3) To explore the risk profile for chronic benzodiazepine use in institutionalised older adults. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Belgium | 1 | <1% |
| Unknown | 119 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 20 | 16% |
| Researcher | 16 | 13% |
| Student > Bachelor | 15 | 12% |
| Student > Ph. D. Student | 14 | 11% |
| Student > Doctoral Student | 8 | 7% |
| Other | 18 | 15% |
| Unknown | 31 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 38 | 31% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 13% |
| Nursing and Health Professions | 14 | 11% |
| Psychology | 9 | 7% |
| Agricultural and Biological Sciences | 4 | 3% |
| Other | 8 | 7% |
| Unknown | 33 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2013.
All research outputs
#20,210,424
of 22,731,677 outputs
Outputs from European Journal of Clinical Pharmacology
#2,382
of 2,553 outputs
Outputs of similar age
#220,559
of 243,300 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#27
of 32 outputs
Altmetric has tracked 22,731,677 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,553 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,300 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.